Skip to main content
ORNL metabolic engineer Adam Guss develops genetic tools to modify microbes that can perform a range of processes needed to create sustainable biofuels and bioproducts. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

As a metabolic engineer at Oak Ridge National Laboratory, Adam Guss modifies microbes to perform the diverse processes needed to make sustainable biofuels and bioproducts.

At Oak Ridge National Laboratory, Carly Hansen combines her passion for research and her commitment to protecting water resources. Hansen’s research covers topics from development opportunities at non-powered dams to hydropower storage capacity. Credit: Genevieve Martin, ORNL/U.S. Dept. of Energy.

Carly Hansen, a water resources engineer at Oak Ridge National Laboratory, is rethinking what’s possible for hydropower in the United States.

Jianlin Li, leader of the Energy Storage and Conversion Manufacturing Group, directs the development of advanced manufacturing schemes and pilot-scale devices into emerging energy storage and conversion research. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

In his career focused on energy storage science, Jianlin Li has learned that discovering new ways to process and assemble batteries is just as important as the development of new materials.

Computational biophysicist Ada Sedova is using experiments and high-performance computing to explore the properties of biological systems and predict their form and function, including research to accelerate drug discovery for COVID-19. Photo credit: Jason Richards, Oak Ridge National Laboratory, U.S. Dept. of Energy.

Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology

Omar Demerdash

With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.